Changes in ConA, SNA and WGA binding relative to P-gp expression were also observed in human myeloid leukemia SKM-1 (overexpressing P-gp due to selection with vincristine and lenalidomide) and MOLM-13 (overexpressing P-gp due to selection with vincristine) cells [19]. This evidence concerns the gene PGP and myeloid leukemia.